Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

Tumor Necrosis Factor Alpha as a Predictive Biomarker for Hirschsprung-Associated Enterocolitis: A Case-Control Study

Breadcrumb

  • Home
  • Tumor Necrosis Factor Alpha As a Predictive Biomarker For Hirschsprung-Associated Enterocolitis: A Case-Control Study
  • Tumor Necrosis Factor Alpha as a Predictive Biomarker for Hirschsprung-Associated Enterocolitis: A Case-Control Study

Ali Alsaeidi 1, *, Lulik Inggarwati 2, Mohammed Husyan Jaabh 3, Holipah 4, Wisnu Barlianto 5, M. Luqman Fadli 6, Mohammed Jamaleldeen 7 and Happy Kurnia Permatasari 8

1 Medical Science Doctoral Program, Faculty of Medicine, Universitas Syiah Kuala, Banda Aceh, Indonesia.
2 Department of Pediatric Surgery, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
3 Anaesthesia and Intensive Care Department, Elmergib University, Alkhums, Libya.
4 Department of Public Health, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
5 Pediatric Department, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
6 Department of Anatomical Pathology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
7 Biomedical Science Master Program, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
8 Department of Biochemistry, Biomolecular, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia.
Research Article
GSC Biological and Pharmaceutical Sciences, 2025, 33(01), 190-195.
Article DOI: 10.30574/gscbps.2025.33.1.0393
DOI url: https://doi.org/10.30574/gscbps.2025.33.1.0393
Received on 07 September 2025; revised on 14 October 2025; accepted on 16 October 2025
Background: The most dangerous consequence of Hirschsprung's disease (HD) is Hirschsprung-associated enterocolitis (HAEC), which can have a 30% fatality rate. Due to a lack of trustworthy biomarkers, early diagnosis and prediction are still difficult. The expression of tumor necrosis factor alpha (TNF-α) was examined in this study as a potential biomarker for the development of HAEC.
Methods: From January 2024 to June 2025, a case-control study was carried out at the Dr. Saiful Anwar Hospital in Malang, Indonesia. Twelve children were recruited, five of whom had HAEC and seven of whom had HD without. Both ganglionic and aganglionic intestinal segments were subjected to histopathological investigation utilizing hematoxylin and eosin staining and immunohistochemistry evaluation of TNF-α expression. The number of positive cells per high-power field was used to quantify TNF-α expression.
Results: In the aganglionic segments of HAEC patients, TNF-α expression was substantially higher than that of HD patients (50.80 ± 8.47 vs. 25.14 ± 6.23 positive cells/field; p = 0.0127). Ganglionic segments did not significantly differ across groups (28.20 ± 5.67 vs. 21.43 ± 5.24; p = 0.0778). More severe histological grades, including neutrophil infiltration, mucosal ulceration, and widespread crypt abscesses, were seen in HAEC patients.
Conclusions: The expression of TNF-α in aganglionic segments is a trustworthy biomarker for the development of HAEC. In order to improve patient outcomes, elevated TNF-α levels may aid in early diagnosis and direct focused therapy measures.
Hirschsprung Disease; Enterocolitis; TNF-Alpha; Biomarker; Inflammation; Pediatric Surgery
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2025-…

Preview Article PDF

Ali Alsaeidi, Lulik Inggarwati, Mohammed Husyan Jaabh, Holipah, Wisnu Barlianto, M. Luqman Fadli, Mohammed Jamaleldeen and Happy Kurnia Permatasari. Tumor Necrosis Factor Alpha as a Predictive Biomarker for Hirschsprung-Associated Enterocolitis: A Case-Control Study. GSC Biological and Pharmaceutical Sciences, 2025, 33(1), 190-195. Article DOI: https://doi.org/10.30574/gscbps.2025.33.1.0393


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution